http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-013498-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
| filingDate | 1998-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2000-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-013498-A1 |
| titleOfInvention | USE OF IFN-ALPHA AND AMANTADINE FOR THE TREATMENT OF CHRONIC HEPATITIS C USE OF IFN-ALPHA |
| abstract | The present invention provides the use of IFN-alpha in association with amantadine for the manufacture of drugs for the treatment of chronic hepatitis C infections. The present invention also provides drugs containing IFN-alpha and amantadine as a combined preparation for simultaneous, separate or sequential therapy of chronic hepatitis C infections. The present invention further provides a method of treating chronic hepatitis C infections in patients in need of such treatment comprising administering an amount of IFN-alpha in association with an amount of amantadine that is effective in treating hepatitis C. |
| priorityDate | 1997-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.